When a fixed regulatory deadline meets withheld evidence and shifting interpretations, questions follow. This open letter examines how the UK Food Standards Agency has applied its CBD novel foods rules—and whether those decisions can be properly scrutinised.

Despite the FSA’s assurance that assessments will continue, it is difficult to see how any applications could progress much further. Furthermore, authorisations ultimately require ministerial approval, and it is those same ministers who are currently negotiating the SPS agreement rather than the FSA.

The 10mg ADI simply does not hold up, even for synthetic CBD, especially if a 300UF is likely excessive. Furthermore, the FSA’s exclusion of

Do you ever get the sense that cold press hemp oil is a 'problem'? I don't mean for any associations who're protecting their members interes